why choose us

First received: May 31, 2023

Clinical Trial: Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Chronic Hepatitis C

Study Type: INTERVENTIONAL


Official Title: Treatment of Recent Injection Drug Use With Chronic HCV Infection in U.S. Liver Referral Clinics: A Prospective, Observational Cohort Study And Contemporaneous Therapy Cohort Without Injection Drug Us

Brief Summary: Direct antiviral therapy (standard of care) administered to chronic hepatitis C-infected patients, in two hepatology clinics, who had used intravenous drugs in the past 6 months of signing informed consent (IC).This cohort was compared to concurrently treated chronic hepatitis C patients who were not intravenous drug users, who signed IC in these same clinics.Follow-up expected two years after cure and relapse rates recorded.Primary end point was SVR rate and secondary end points included reinfection rates in…

Read more